144 related articles for article (PubMed ID: 33040789)
1. Long noncoding RNA H19 promotes vincristine resistance in multiple myeloma by targeting Akt.
Wang Y; Xu S; Wang L; Liu J; Wang J; Zhou J
Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):76-80. PubMed ID: 33040789
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells.
Tsubaki M; Takeda T; Ogawa N; Sakamoto K; Shimaoka H; Fujita A; Itoh T; Imano M; Ishizaka T; Satou T; Nishida S
Leuk Res; 2015 Apr; 39(4):445-52. PubMed ID: 25726084
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
Zhang HR; Chen JM; Zeng ZY; Que WZ
J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
Yu S; Wu C; Tan Q; Liu H
J Cell Biochem; 2019 Sep; 120(9):15131-15144. PubMed ID: 31020694
[TBL] [Abstract][Full Text] [Related]
5. [Wnt5a modulates vincristine resistance through PI3K/Akt/GSK3β signaling pathway in human ovarian carcinoma SKOV3/VCR cells].
Wu FL; Chen HL; Hu XW; Liang LY; Xu WL
Sheng Li Xue Bao; 2019 Jun; 71(3):415-423. PubMed ID: 31218332
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p.
Zheng JF; Guo NH; Zi FM; Cheng J
Mol Cell Biol; 2020 Jan; 40(3):. PubMed ID: 31712391
[TBL] [Abstract][Full Text] [Related]
7. BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells.
Yang W; Zhao S; Wu B; Xu J; Wu Z; Guo J; Zeng R
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1279-1288. PubMed ID: 31549215
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of GLI1 in vincristine-resistant rhabdomyosarcoma and Ewing sarcoma.
Yoon JW; Lamm M; Chandler C; Iannaccone P; Walterhouse D
BMC Cancer; 2020 Jun; 20(1):511. PubMed ID: 32493277
[TBL] [Abstract][Full Text] [Related]
9. LncRNA H19/microRNA-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt/mTOR signalling.
Liu Y; Xu L; Lu B; Zhao M; Li L; Sun W; Qiu Z; Zhang B
Mol Immunol; 2019 Dec; 116():18-28. PubMed ID: 31574452
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of long non-coding RNA plasmacytoma variant translocation 1 inhibits cell proliferation while promotes cell apoptosis via regulating miR-486-mediated CDK4 and BCAS2 in multiple myeloma.
Zhang M; Zhao X; Cai X; Wang P; Yu M; Wei Z
Ir J Med Sci; 2020 Aug; 189(3):825-834. PubMed ID: 31900844
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA H19 Inhibits Cell Viability, Migration, and Invasion Via Downregulation of IRS-1 in Thyroid Cancer Cells.
Wang P; Liu G; Xu W; Liu H; Bu Q; Sun D
Technol Cancer Res Treat; 2017 Dec; 16(6):1102-1112. PubMed ID: 29332545
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA H19 promotes proliferation of Hodgkin's lymphoma via AKT pathway.
Wang Y; Wang L; Sui M
J BUON; 2019; 24(2):763-769. PubMed ID: 31128034
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine.
Xie X; Tang B; Zhou J; Gao Q; Zhang P
Oncol Rep; 2013 Aug; 30(2):773-82. PubMed ID: 23743572
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA H19 promotes proliferation of Hodgkin's lymphoma via AKT pathway.
Wang Y; Wang L; Sui M
J BUON; 2018; 23(6):1825-1831. PubMed ID: 30610809
[TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
[TBL] [Abstract][Full Text] [Related]
16. Differential oncogene-related gene expressions in myeloma cells resistant to prednisone and vincristine.
Mutlu P; Ural AU; Gündüz U
Biomed Pharmacother; 2012 Oct; 66(7):506-11. PubMed ID: 22681910
[TBL] [Abstract][Full Text] [Related]
17. Increased 14-3-3ζ expression in the multidrug-resistant leukemia cell line HL-60/VCR as compared to the parental line mediates cell growth and apoptosis in part through modification of gene expression.
Liang R; Chen XQ; Bai QX; Wang Z; Zhang T; Yang L; Dong BX; Gao GX; Gu HT; Zhu HF
Acta Haematol; 2014; 132(2):177-86. PubMed ID: 24603438
[TBL] [Abstract][Full Text] [Related]
18. Identification of long noncoding RNA
Chen T; Sun Z; Cui Y; Ji J; Li Y; Qu X
Hematology; 2023 Dec; 28(1):2164449. PubMed ID: 36657019
[TBL] [Abstract][Full Text] [Related]
19. Exosomal mRNAs and lncRNAs involved in multiple myeloma resistance to bortezomib.
Tang JX; Chen Q; Li Q; He YH; Xiao D
Cell Biol Int; 2021 May; 45(5):965-975. PubMed ID: 33372728
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miRNA-14669 Reverses Vincristine Resistance in Colorectal Cancer Cells through PI3K/AKT Signaling Pathway.
Dong W; Wang F; Liu Q; Wang T; Yang Y; Guo P; Li X; Wei B
Recent Pat Anticancer Drug Discov; 2022; 17(2):178-186. PubMed ID: 34365931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
